PRURITUS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS (NASH) TREATED WITH OBETICHOLIC ACID (OCA)

被引：0
|
作者：
Younossi, Zobair M. [1 ,2 ,3 ]
Stepanova, Maria [4 ]
Nader, Fatema [4 ]
Bonacci, Martin [5 ]
Wong, Bruce [5 ]
Loomba, Rohit [6 ]
Rinella, Mary E. [7 ]
Noureddin, Mazen [8 ]
Harrison, Stephen A. [9 ]
机构：
[1] Inova Hlth Syst, Inova Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[3] Inova Fairfax Med Campus, Dept Med, Ctr Liver Dis, Falls Church, VA USA
[4] Ctr Outcomes Res Liver Dis, Washington, DC USA
[5] Intercept Pharmaceut Inc, New York, NY USA
[6] Univ Calif San Diego, NAFLD Res Ctr, Div Gastroenterol, Dept Med, La Jolla, CA 92093 USA
[7] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60208 USA
[8] Cedars Sinai Med Ctr, Fatty Liver Program, Los Angeles, CA 90048 USA
[9] Pinnacle Clin Res, San Antonio, TX USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1690
引用
收藏
页码：1029 / 1030
页数：2
相关论文
共 50 条
  • [31] Obeticholic Acid improves Fibrosis in NASH-Patients
    Lichert, Frank
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (04): : 302 - 302
  • [32] Predictors of fibrosis in nonalcoholic steatohepatitis (NASH)
    Copaci, I
    Micu, L
    Cojocaru, L
    Voiculescu, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 192 - 192
  • [33] Methylenetetrahydrofolate reductase gene polymorphisms in patients with nonalcoholic steatohepatitis (NASH)
    Sazci, Ali
    Ergul, Emel
    Aygun, Cem
    Akpinar, Gurler
    Senturk, Omer
    Hulagu, Sadettin
    CELL BIOCHEMISTRY AND FUNCTION, 2008, 26 (03) : 291 - 296
  • [34] Nonalcoholic steatohepatitis (NASH) drugs market
    Cassidy, Sorcha
    Syed, Basharut A.
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (11) : 745 - 746
  • [35] Noninvasive evaluation of nonalcoholic steatohepatitis (NASH)
    Mansour-Ghanaei, Fariborz
    Vahhabi-Moghaddam, Masrour
    Joukar, Farahnaz
    Asgharnezhad, Mehrnaz
    Kiyani, Noufar
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2013, 4 (04) : 797 - 798
  • [36] Definition and management of nonalcoholic steatohepatitis (NASH)
    Hütteroth, TH
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 : S64 - S67
  • [37] Nonalcoholic steatohepatitis (NASH): therapeutic approaches
    Buscher, HP
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 : S60 - S62
  • [38] Obeticholic Acid Was Safe and Well Tolerated in Patients with Nonalcoholic Steatohepatitis and Compensated Cirrhosis: A Secondary Analysis of the Control Study
    Halegoua-De Marzio, Dina
    Thuluvath, Paul J.
    Abdelmalek, Manal F.
    Van Biene, Courtney
    Shringarpure, Reshma
    MacConell, Leigh
    HEPATOLOGY, 2018, 68 : 45A - 45A
  • [39] Normal Weight Nonalcoholic Steatohepatitis (NASH)
    Samala, Niharika
    May, Kevin P.
    Kleiner, David E.
    Loomba, Rohit
    Terrault, Norah
    Neuschwander-Tetri, Brent A.
    Hoofnagle, Jay H.
    HEPATOLOGY, 2013, 58 : 495A - 495A
  • [40] Effects of green tea catechins on nonalcoholic steatohepatitis (NASH) patients
    Fukuzawa, Yoshitaka
    Kapoor, Mahendra P.
    Yamasaki, Koji
    Okubo, Tsutomu
    Hotta, Yoshihiro
    Juneja, Lekh Raj
    JOURNAL OF FUNCTIONAL FOODS, 2014, 9 : 48 - 59
12345